These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 31698798)
21. Membrane association facilitates degradation and cleavage of the cyclin-dependent kinase 5 activators p35 and p39. Minegishi S; Asada A; Miyauchi S; Fuchigami T; Saito T; Hisanaga S Biochemistry; 2010 Jul; 49(26):5482-93. PubMed ID: 20518484 [TBL] [Abstract][Full Text] [Related]
22. The role of CDK5/P25 formation/inhibition in neurodegeneration. Camins A; Verdaguer E; Folch J; Canudas AM; Pallàs M Drug News Perspect; 2006 Oct; 19(8):453-60. PubMed ID: 17160145 [TBL] [Abstract][Full Text] [Related]
23. Partial rescue of the p35-/- brain phenotype by low expression of a neuronal-specific enolase p25 transgene. Patzke H; Maddineni U; Ayala R; Morabito M; Volker J; Dikkes P; Ahlijanian MK; Tsai LH J Neurosci; 2003 Apr; 23(7):2769-78. PubMed ID: 12684463 [TBL] [Abstract][Full Text] [Related]
24. Regulation and role of cyclin-dependent kinase activity in neuronal survival and death. Hisanaga S; Endo R J Neurochem; 2010 Dec; 115(6):1309-21. PubMed ID: 21044075 [TBL] [Abstract][Full Text] [Related]
29. Mammalian Cdk5 is a functional homologue of the budding yeast Pho85 cyclin-dependent protein kinase. Huang D; Patrick G; Moffat J; Tsai LH; Andrews B Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14445-50. PubMed ID: 10588725 [TBL] [Abstract][Full Text] [Related]
31. Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation. Sharma P; Sharma M; Amin ND; Albers RW; Pant HC Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11156-60. PubMed ID: 10500146 [TBL] [Abstract][Full Text] [Related]
32. The role of Cdk5 in retinoic acid-induced apoptosis of cervical cancer cell line. Kuo HS; Hsu FN; Chiang MC; You SC; Chen MC; Lo MJ; Lin H Chin J Physiol; 2009 Feb; 52(1):23-30. PubMed ID: 19764350 [TBL] [Abstract][Full Text] [Related]
33. The inhibition of Cdk5 activity after hypoxia/ischemia injury reduces infarct size and promotes functional recovery in neonatal rats. Tan X; Chen Y; Li J; Li X; Miao Z; Xin N; Zhu J; Ge W; Feng Y; Xu X Neuroscience; 2015 Apr; 290():552-60. PubMed ID: 25665755 [TBL] [Abstract][Full Text] [Related]
34. Extraneuronal activities and regulatory mechanisms of the atypical cyclin-dependent kinase Cdk5. Arif A Biochem Pharmacol; 2012 Oct; 84(8):985-93. PubMed ID: 22795893 [TBL] [Abstract][Full Text] [Related]
35. Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells. Lee JH; Kim KT J Neurochem; 2004 Nov; 91(3):634-47. PubMed ID: 15485494 [TBL] [Abstract][Full Text] [Related]
37. Transient enhanced expression of Cdk5 activator p25 after acute and chronic d-amphetamine administration. Mlewski EC; Krapacher FA; Ferreras S; Paglini G Ann N Y Acad Sci; 2008 Oct; 1139():89-102. PubMed ID: 18991853 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of aberrant cyclin-dependent kinase 5 activity attenuates isoflurane neurotoxicity in the developing brain. Wang WY; Luo Y; Jia LJ; Hu SF; Lou XK; Shen SL; Lu H; Zhang HH; Yang R; Wang H; Ma ZW; Xue QS; Yu BW Neuropharmacology; 2014 Feb; 77():90-9. PubMed ID: 24055498 [TBL] [Abstract][Full Text] [Related]
39. Crosstalk between cdk5 and MEK-ERK signalling upon opioid receptor stimulation leads to upregulation of activator p25 and MEK1 inhibition in rat brain. Ramos-Miguel A; García-Sevilla JA Neuroscience; 2012 Jul; 215():17-30. PubMed ID: 22537847 [TBL] [Abstract][Full Text] [Related]
40. The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis. Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T Biochem Biophys Res Commun; 2001 Feb; 280(4):998-1002. PubMed ID: 11162625 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]